Literature DB >> 11160210

Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.

T R Malek1, A Yu, P Scibelli, M G Lichtenheld, E K Codias.   

Abstract

Coincident production of IL-2 and induction of high-affinity IL-2R upon TCR engagement has precluded a clear distinction for the biological outcome of signaling through TCR/costimulatory molecules vs the IL-2R. Using a novel transgenic mouse on the IL-2Rbeta(-/-) genetic background, this study has separated the relative outcome of signaling through the TCR and IL-2R. We show that stimulation through the TCR and CD28 or CD40 ligand directly leads to T cell activation and several rounds of proliferation in an IL-2-independent fashion. However, this stimulation is insufficient for extended T cell growth to multiple cytokines or differentiation into CTL or IFN-gamma-secreting effector T cells. IL-2 is required for these functions in part by regulation of cyclin D3 and granzyme B. Somewhat less efficiently, IL-4 stimulation of these transgenic T cells redundantly rescued many of these activities. These data demonstrate a fundamental requirement for IL-2 and perhaps other common gamma-chain-dependent cytokines to promote selective gene expression by Ag-activated T cells for their subsequent growth and differentiation into effector T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160210     DOI: 10.4049/jimmunol.166.3.1675

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  The transcriptional control of the perforin locus.

Authors:  Matthew E Pipkin; Anjana Rao; Mathias G Lichtenheld
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Allogeneic T regulatory cell-mediated transplantation tolerance in adoptive therapy depends on dominant peripheral suppression and central tolerance.

Authors:  Dennis Adeegbe; Robert B Levy; Thomas R Malek
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

3.  The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.

Authors:  Iris Castro; Aixin Yu; Michael J Dee; Thomas R Malek
Journal:  J Immunol       Date:  2011-10-07       Impact factor: 5.422

4.  Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function.

Authors:  Fany M Iseka; Benjamin T Goetz; Insha Mushtaq; Wei An; Luke R Cypher; Timothy A Bielecki; Eric C Tom; Priyanka Arya; Sohinee Bhattacharyya; Matthew D Storck; Craig L Semerad; James E Talmadge; R Lee Mosley; Vimla Band; Hamid Band
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

Review 5.  The potential for genetically altered microglia to influence glioma treatment.

Authors:  W Li; R M D Holsinger; C A Kruse; A Flügel; M B Graeber
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-09       Impact factor: 4.388

6.  A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells.

Authors:  Allison L Bayer; Joon Youb Lee; Anabel de la Barrera; Charles D Surh; Thomas R Malek
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Authors:  Victor Peperzak; Yanling Xiao; Elise A M Veraar; Jannie Borst
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

8.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells.

Authors:  Aixin Yu; Linjian Zhu; Norman H Altman; Thomas R Malek
Journal:  Immunity       Date:  2009-01-29       Impact factor: 31.745

9.  The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity.

Authors:  Linda A Lieberman; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-06-06

10.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.